Stockhead on MSN12h
The storied Australian drug developer turning his skills to funds management
The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.
Yahoo Finance3d
Simulations Plus, Inc. (SLP)
After hours: December 31 at 6:03:21 p.m. EST ...